Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and delivery of immune-based therapies for patients around the world. Zenas is rapidly advancing a deep portfolio of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com.

Longitude Capital

Superstring Capital

Tellus BioVentures

Fairmount Funds Management

Perceptive Advisors

Pivotal bioVenture Partners

Quan Capital

Vivo Capital

Wellington Management

Xencor

Zenas BioPharma

Domain Not Resolving

CrUX Dataset

CrUX Top 10m

Gravity Forms

Chief Operating Officer (USA)

Heidi Kempinski

President and Chief Operating Officer

Joe Farmer

Vice President Clinical Development

Allen Poma

VP, Global Quality Assurance

Bill Gaskins

Vice President, FP&A

Drew McDevitt

Senior Vice President, Global Clinical Development Operations

Eric Haltom

Vice President, Pharmacovigilance

Mason Yamashita

Vice President, New Product Planning and Commercial Strategy

Paul Korathu

Senior Vice President, Global Head of Regulatory Affairs & Quality at Zenas BioPharma

Richard Mountfield

VP, Clinical Development

Stephen Wax

Jake Nunn

Tim Xiao

James Boylan

Patrick Enright

Tomas Kiselak

Hua Mu

John Orloff

Marietta Wu

Chief Executive Officer

Orlando Oliveira

Chief Commercial Officer

Simon Lowry

Chief Medical Officer

Lonnie Moulder Jr

Founder, Board Member, Executive Chairman and Chief Executive Officer

Mark Matijevic

Senior Director, Translational Research

Northeastern US Companies With More Than 50 Employees (Top 10K)

Health Care Companies With Fewer Than 100 Employees (Top 10K)

Health Care Companies With Less Than $500M in Revenue (Top 10K)

Greater Boston Area Companies (Top 10K)

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.

Delos Capital

New Enterprise Associates

Norwest Venture Partners

SR One

Series C - Zenas BioPharma

Enavate Sciences

Series B - Zenas BioPharma

Series A - Zenas BioPharma

Waltham

Massachusetts

United States

North America

Amid broader uncertainty, biopharma market may have reached 'new norm': PitchBook

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

North American Startup Funding Weakened In Q3 As Largest Deal Took Longer To Close

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO

Zenas BioPharma files initial public offering

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Zenas BioPharma Weighs $150 Million-Plus IPO as Soon as July

The 10 Biggest Rounds Of May: xAI And CoreWeave Lead Big Month For AI

A bifunctional, non-cytolytic, humanized monoclonal antibody targeting CD19 and FcγRIIb to inhibit B-cell activity, in Phase 3 for IgG4-Related Disease and warm autoimmune hemolytic anemia.

An anti-TNFα therapy with extended half-life and reduced off-target activity, aiming for Best-in-Class status.

A CTLA4-Ig fusion protein with enhanced half-life and potency, positioned as a potential Best-in-Class therapy.

An insulin-like growth factor-1 receptor monoclonal antibody for thyroid eye disease, with First-in-Class potential in China.

United Kingdom

Europe

Indonesia

Asia

India

South Korea

Associate Director, Clinical Scientist

Clinical Scientist

Senior Medical Science Liaison

Senior Medical Science Liaison (50% allocation to Clinical Development)

Medical Science Liaison

Postdoctoral Fellow

Postdoctoral Research Fellow

Graduate Student/Research Assistant/Teaching Fellow

Clinical Scientist at Zenas BioPharma | Clinical Development & Research | Clinical Trial Activities | KOL Engagement | Scientific & Medical Communication

Audrey Wells

Executive Director, Translational Research

Director - Senior Director, Translational Research, Biomarker Discovery and Development

Research Investigator - Associate Director, Translational Biomedicine

Scientist - Senior Scientist

Senior Research Associate

Senior Research Associate - Scientist

Laboratory Technician I - III

Executive Director, Translational Research at Zenas BioPharma

Executive Director, Site Relationship & Clinical Monitoring

FDA Safety Federal Advisory Committee (SGE)

Clinical Research - Operations Professional

Senior Director, Clinical Development Operations -Gene Therapy

Director, Clinical Development & Operations - Gene Therapy

Assoc. Director, Clinical Operations and Field Lead

Clinical Research Coordinator

Medical Clinical Coordinator

Medical Director and Entrepreneur

Innovative, Gene Therapy, immunotherapy, and cell therapy Operations Leader

Jose Silveiras

Executive Director, Strategic Sourcing and Vendor Management

Senior Consultant

Senior Director, Sourcing and Vendor Management

Sr. Director, Research & Early Development Operations

Sr. Director, GCD Central Operations

Director/Senior Director, Operational Analysis

Associate Director R&D Finance

Sr. Financial Analyst/ Manager Finance Business Partner

Sr. Manager, Finance, Contracts and Outsourcing

Business Operations | People Leadership | Program/Project Management | Analytics

Chris O'Brien

Senior Director, Quality Systems and Compliance

Director GxP Training and Documentation

Associate Director GxP Training and Documentation

Senior Manager Quality Assurance

Documentation Lead

Senior Director, Quality Systems and Compliance at Zenas BioPharma

Thomas Broadbent

Director, Clinical Trial Material Supply Management

Senior Manager, Supply Chain

Senior Manager, Clinical Trial Supply

Manager, Clinical Trial Supply

Clinical Supplies Manager

Senior Manager, Clinical Supplies

Clinical Supplies Associate

Research Compliance Coordinator

Clinical Research Associate

Compliance Auditor

Coder

Beth Smith

Sr. Director, Statistical Programming

Senior Director, Clinical Data Solutions and Sciences

Senior Director, Statistical Programming

Director, Statistical Programming

Associate Director, Statistical Programming

Principal Programmer

Principal (Statistical) Analyst

Sr. Statistical Programmer

Sr. Statistical Analyst/Programmer

Mubing Li

Executive Director

Senior Director

Director

Principal Scientist

Sr.Scientist

Boxu Yan

Executive Director, Head of Medical and Scientific Affairs

Director, Clinical Development

Associate Director, Clinical Development

Clinical Scientist, Clinical Development

Shauna Quinn

Chief Human Resources Officer

Senior Vice President Human Resources

Vice President, Human Resources

Vice President, Total Rewards & People Operations

Senior Director, HR Operations

Senior Director, Total Rewards & HR Operations

Director, HR Operations & Benefits

Director, Global Benefits

Senior Benefits Manager

Benefits Manager

Sr. HR Analyst

Chief Human Resources Officer at Zenas BioPharma

Caroline Chevalier

Executive Director, Head of Biostatistics

Senior Director, Head of Biostatistics

Director of Biostatistics

Statistics Leader

Independent Statistical Consultant

Senior Principal Biostatistician

Director, Biostatistics

Biostatistical Specialist

Senior Statistician

Statistician II

Executive Director, Head of Biostatistics at Zenas BioPharma

Sujata Arora

Associate Director, Analytical Development & Quality Control

Analytical CMC Scientist

Analytical Associate

QC Supervisor

Lab Technician

A biotechnology enthusiast

Haytham Samhouri

news impact assignment basic	general
public peers	general
news daily refresh	general	Jul 25, 2024 12:00 PM	bfe218c3
news processing daily refresh	general	May 23, 2024 4:37 AM	b718c340
news impact assignment daily	general	May 23, 2024 4:37 AM	3a3ecb65
news processing basic	general
company summary	general	May 23, 2024 4:40 AM	90afda4d
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	a47494ba
crunchbase profile	general	Nov 27, 2024 12:55 PM	a747028e
li profile	general
translate crunchbase fundingrounds	general	Nov 27, 2024 2:01 PM	90e20ca0
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ZBIO

COM:ZENASBIO

Zenas BioPharma

Last Close

10.44

22/11 21:00

Market Cap

2.50M

Beta: -

Volume Today

785.07K

Avg: -